3D Medicines (HKSE:01244) Total Assets : HK$1,562.9 Mil (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is 3D Medicines Total Assets?

3D Medicines's Total Assets for the quarter that ended in Dec. 2023 was HK$1,562.9 Mil.

During the past 12 months, 3D Medicines's average Total Assets Growth Rate was 8.60% per year. During the past 3 years, the average Total Assets Growth Rate was 69.50% per year.

During the past 4 years, 3D Medicines's highest 3-Year average Total Assets Growth Rate was 69.50%. The lowest was 69.50%. And the median was 69.50%.

Total Assets is connected with ROA %. 3D Medicines's annualized ROA % for the quarter that ended in Dec. 2023 was -49.90%. Total Assets is also linked to Revenue through Asset Turnover. 3D Medicines's Asset Turnover for the quarter that ended in Dec. 2023 was 0.20.

3D Medicines Total Assets Historical Data

The historical data trend for 3D Medicines's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

3D Medicines Total Assets Chart

3D Medicines Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Total Assets

588.23

1,298.29

1,487.53

1,562.88

3D Medicines Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
Total Assets	Get a 7-Day Free Trial			1,298.29	-	1,487.53	1,472.51	1,562.88

3D Medicines Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

3D Medicines's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	952.337	+	610.544
	=	1,562.9

3D Medicines's Total Assets for the quarter that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (Q: Dec. 2023 )	+	Total Liabilities (Q: Dec. 2023 )
	=	952.337	+	610.544
	=	1,562.9

3D Medicines (HKSE:01244) Total Assets Explanation

Total Assets is connected with ROA %.

3D Medicines's annualized ROA % for the quarter that ended in Dec. 2023 is

ROA %	=	Net Income (Q: Dec. 2023 )	/	( (Total Assets (Q: Jun. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
	=	-757.358	/	( (1472.514	+	1562.881)	/ 2 )
	=	-757.358	/	1517.6975
	=	-49.90 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

3D Medicines's Asset Turnover for the quarter that ended in Dec. 2023 is

	Asset Turnover
=	Revenue (Q: Dec. 2023 )	/	( (Total Assets (Q: Jun. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
=	308.879	/	( (1472.514	+	1562.881)	/ 2 )
=	308.879	/	1517.6975
=	0.20

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

3D Medicines Total Assets Related Terms

Thank you for viewing the detailed overview of 3D Medicines's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

3D Medicines (HKSE:01244) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 3D Medicines Inc (HKSE:01244) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 3 and No. 5, Laiyang Road, Shandong, Qingdao, CHN

Website

https://www.3d-medicines.com

3D Medicines Inc is a commercial-stage biopharmaceutical company that researches, develops, and commercialization of drugs in the field of managing cancer as a chronic disease. It develops differentiated immuno-oncology drugs, helping cancer patients live with prolonged survival time and quality of life.

Executives

Gong Zhaolong	2101 Beneficial owner
Zhu Pai	2101 Beneficial owner
Dragon Prosper Holdings Limited	2101 Beneficial owner
Simcere Pharmaceutical Group Limited	2101 Beneficial owner
Gong Zhaolong	2501 Other
Immunal Medixin Us Limited	2101 Beneficial owner
Kastle Limited
Shanghai Zhenlu Enterprise Management Consulting Partnership (limited Partnership)	2101 Beneficial owner
Shenzhen Efung Holding Co., Ltd.	2201 Interest of corporation controlled by you
Shenzhen Efung Investment Management Enterprise (l.p.)	2201 Interest of corporation controlled by you
Shenzhen Efung Ruishi Investment Enterprise (limited Partnership)	2201 Interest of corporation controlled by you
Zhu Jinqiao	2103 Interests held jointly with another person

3D Medicines (HKSE:01244) Headlines

No Headlines